Anticipation. The bulk of who's been following this is simply waiting for further developments. The FDA for Fluticare would be the most tangible but of course increasing revs without it is also a key to keep us holding onto the hook. Dr. D really can't specify a true timeline for something that's out of his control. Finagling with the share structure certainly makes people nervous. But again, that's only on paper. The immediate conversions recently is the only thing really messing with the float. Those that want to be on board moving into earnings and possible approval, are on or on the trigger imo. Everyone else just has this on their watch list, hopefully with news alerts and a couple price alerts set near support/resistance.
Deciding to divide my recent gains from another play between here or elsewhere or just on another play while this is sideways.
Market Data 
Markets 
AI
